Talbot George Harrison

CIK 00015541943 companiesMORRISTOWN, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001554194

Recent Transactions

28 trades

Award
Nabriva Therapeutics plc
Ordinary Shares
2020-07-29+17,500→ 65,140 total
Award
Nabriva Therapeutics plc
Stock Options
2020-07-29+35,000→ 35,000 total
Award
Nabriva Therapeutics plc
Stock Option
2019-07-31+35,000→ 35,000 total
Purchase
Nabriva Therapeutics plc
Ordinary Shares
2018-07-31$2.75/sh+14,500→ 47,640 total
Award
Nabriva Therapeutics plc
Stock Option
2018-05-02+29,000→ 29,000 total
Exercise/Conversion
Nabriva Therapeutics plc
Ordinary Shares
2017-09-27+1,350→ 33,140 total
Exercise/Conversion
Nabriva Therapeutics plc
Stock Option
2017-09-27−1,350→ 0 total
Award
Nabriva Therapeutics plc
Stock Option
2017-09-15+10,100→ 10,100 total
Other
Nabriva Therapeutics Legacy plc
Stock Option
2017-06-23+40,000→ 40,000 total
Other
Nabriva Therapeutics Legacy plc
Ordinary Shares
2017-06-23+31,790→ 31,790 total
Other
Nabriva Therapeutics Legacy plc
Stock Option
2017-06-23+10,100→ 10,100 total
Sale
Nabriva Therapeutics plc
Common Shares
2017-06-19$91.00/sh−46→ 3,179 total
Sale
Nabriva Therapeutics plc
Common Shares
2017-06-16$93.50/sh−24→ 3,225 total
Sale
Nabriva Therapeutics plc
Common Shares
2017-06-15$94.10/sh−100→ 3,249 total
Sale
Nabriva Therapeutics plc
Common Shares
2017-05-30$101.00/sh−100→ 3,349 total
Sale
Nabriva Therapeutics plc
Common Shares
2017-05-30$101.50/sh−110→ 3,449 total
Sale
Nabriva Therapeutics plc
Common Shares
2017-05-25$101.00/sh−90→ 3,559 total
Sale
Nabriva Therapeutics plc
Common Shares
2017-05-25$100.50/sh−205→ 3,649 total
Sale
Nabriva Therapeutics plc
Common Shares
2017-05-23$99.70/sh−30→ 3,854 total
Sale
Nabriva Therapeutics plc
Common Shares
2017-05-16$103.00/sh−100→ 3,884 total
Sale
Nabriva Therapeutics plc
Common Shares
2017-05-16$102.27/sh−50→ 3,984 total
Sale
Nabriva Therapeutics plc
Common Shares
2017-05-15$101.50/sh−50→ 4,034 total
Exercise/Conversion
Nabriva Therapeutics plc
Common Shares
2017-02-16+502→ 3,351 total
Exercise/Conversion
Nabriva Therapeutics plc
Common Shares
2017-02-16+578→ 4,084 total
Exercise/Conversion
Nabriva Therapeutics plc
Stock Option
2017-02-16−578→ 135 total
Exercise/Conversion
Nabriva Therapeutics plc
Stock Option
2017-02-16−155→ 0 total
Exercise/Conversion
Nabriva Therapeutics plc
Stock Option
2017-02-16−502→ 0 total
Exercise/Conversion
Nabriva Therapeutics plc
Common Shares
2017-02-16+155→ 3,506 total

Companies

Recent Filings

Address

C/O DURATA THERAPEUTICS, INC. 89 HEADQUARTERS PLAZA NORTH, 14TH FLOOR

MORRISTOWN, NJ, 07960

View on SEC.gov